Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

This study has been terminated.
(End of recruitment period)
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00224575
First received: September 13, 2005
Last updated: September 29, 2009
Last verified: April 2008
  Purpose

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.


Condition Intervention
Myocardial Ischemia
Other: diagnosis reassessment
Other: Diagnosis strategy and subsequent therapeutic reassessment

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly [ Time Frame: during hospitalization ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]

Enrollment: 260
Study Start Date: November 2004
Study Completion Date: November 2006
Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
All patients are in that arms. They all receive the diagnosis reassessment strategy.
Other: diagnosis reassessment
Strategy of diagnosis reassessment following a decision tree.
Other Name: no other names to specified
Other: Diagnosis strategy and subsequent therapeutic reassessment
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

Detailed Description:

not desired

  Eligibility

Ages Eligible for Study:   75 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria:

  • acute myocardial infarction
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00224575

Locations
France
Hopital Bichat
Paris, France, 75018
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: legrain sylvie APHP
  More Information

No publications provided

Responsible Party: Zakia IDIR, Department Clinical Rechearch of Developpement
ClinicalTrials.gov Identifier: NCT00224575     History of Changes
Other Study ID Numbers: AOM03099
Study First Received: September 13, 2005
Last Updated: September 29, 2009
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Veterans

Additional relevant MeSH terms:
Myocardial Ischemia
Coronary Artery Disease
Coronary Disease
Heart Diseases
Ischemia
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on April 17, 2014